Skip to main content
OpenTrials
Completed

NCT Number: NCT01751204

Comparison of Absorbability Between Calcium Tablet and Calcium Ion Water

The purpose of this study is to evaluate the absorbability of calcium tablet and calcium ion water.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

55 year–70 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Hiroshima University

Hiroshima, 734-8551, Japan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Postmenopausal females

Exclusion criteria

  • Taking medicines or functional food that affect serum calcium levels
  • Diseases that affect bone
  • Renal or hepatic dysfunction
  • Heart disease
  • Participation in any clinical trial within 90 days of the commencement of the trial

Treatment and study plan

Calcium tablet

Dietary Supplement

Calcium ion water (250mg)

Dietary Supplement

Calcium ion water (125mg)

Dietary Supplement

Primary outcomes

  1. Serum calcium profile (including AUC, Cmax, and Tmax)

    Time frame: Overall 2 hours

Sponsors and collaborators

Lead sponsor

Hiroshima University

Other

Collaborators

  • CHUGOKU KAYAKU CO., LTD.

Registry information

Official study title

A Randomized, Double-blind, Crossover Study to Compare the Absorbability Between Calcium Tablet and Calcium Ion Water

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Dec 17, 2012
Registry last updated
Mar 28, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.